{"date":"2026-08-21","count":36,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4178-2026-08-21-2154-13psaf0","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"21:54:50","subject":"代重要子公司Stemcyte, Inc.(美國永生公司)公告總經理異動","clause":"第6款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-08-21 21:54，「代重要子公司Stemcyte, Inc.(美國永生公司)公告總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-08-21-2151-1ca0cdc","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"21:51:52","subject":"公告本公司董事異動","clause":"第6款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-08-21 21:51，「公告本公司董事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-08-21-2146-on65kl","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"21:46:02","subject":"公告董事會決議解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-08-21 21:46，「公告董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-08-21-2139-wr0tu2","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"21:39:55","subject":"公告本公司總經理異動","clause":"第6款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-08-21 21:39，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-08-21-2137-fkzy5x","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"21:37:23","subject":"公告本公司訴訟及非訴訟代理人異動","clause":"第8款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-08-21 21:37，「公告本公司訴訟及非訴訟代理人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-08-21-2133-37n2dy","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"21:33:51","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-08-21 21:33，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-08-21-2128-1unnh97","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"21:28:33","subject":"公告本公司研發及製造主管異動","clause":"第8款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-08-21 21:28，「公告本公司研發及製造主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-08-21-2123-1vhu1xi","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"21:23:40","subject":"公告本公司發言人異動","clause":"第8款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-08-21 21:23，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-08-21-2110-nlrj5c","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-08-21","time":"21:10:06","subject":"本公司註銷庫藏股辦理資本變更登記完成","clause":"第36款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-08-21 21:10，「本公司註銷庫藏股辦理資本變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-08-21-2003-1knaqum","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-08-21","time":"20:03:08","subject":"代重要子公司Belite Bio, Inc公告受邀參加第19屆亞太玻璃體視網膜學會2026年會(APVRS 2026)","clause":"第44款","fact_date":"2026-08-29","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-08-21 20:03，「代重要子公司Belite Bio, Inc公告受邀參加第19屆亞太玻璃體視網膜學會2026年會(APVRS 2026)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-08-21-2002-iih19f","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-08-21","time":"20:02:41","subject":"代重要子公司Belite Bio, Inc公告受邀參加瑞士眼科學會2026年會(SOG 2026)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-08-21 20:02，「代重要子公司Belite Bio, Inc公告受邀參加瑞士眼科學會2026年會(SOG 2026)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-08-21-1957-f3j6pe","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"19:57:23","subject":"本公司董事會通過新加坡子公司Lotus International Pte. Ltd.向Alvotech hf.取得兩項開發中生物相似藥授權","clause":"第20款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-21 19:57，「本公司董事會通過新加坡子公司Lotus International Pte. Ltd.向Alvotech hf.取得兩項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-08-21-1952-2u9j09","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"19:52:25","subject":"公告本公司召開重大訊息記者會內容","clause":"第51款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-21 19:52，「公告本公司召開重大訊息記者會內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-08-21-1808-6ashb","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"18:08:15","subject":"公告本公司新任經理人案","clause":"第6款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-08-21 18:08，「公告本公司新任經理人案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-08-21-1807-1bd9vl2","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"18:07:35","subject":"代克麗緹娜集團有限公司等重要子公司公告董事異動","clause":"第6款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-08-21 18:07，「代克麗緹娜集團有限公司等重要子公司公告董事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-08-21-1806-18o8ack","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"18:06:22","subject":"代子公司香港克麗緹娜國際有限公司及其他子公司公告現金增資案","clause":"第20款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-08-21 18:06，「代子公司香港克麗緹娜國際有限公司及其他子公司公告現金增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-08-21-1805-c6a28l","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"18:05:51","subject":"代子公司康岑（上海）企業管理有限公司公告新增轉投資案","clause":"第20款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-08-21 18:05，「代子公司康岑（上海）企業管理有限公司公告新增轉投資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-08-21-1805-y6tzjw","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"18:05:20","subject":"代子公司克麗緹娜（中國）貿易有限公司公告新增轉投資案","clause":"第20款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-08-21 18:05，「代子公司克麗緹娜（中國）貿易有限公司公告新增轉投資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-08-21-1804-ne7t2t","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"18:04:52","subject":"本公司董事會決議115年第二季不分派股利","clause":"第14款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-08-21 18:04，「本公司董事會決議115年第二季不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-08-21-1804-sn763a","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"18:04:16","subject":"公告本公司董事會決議通過115年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-08-21 18:04，「公告本公司董事會決議通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-08-21-1803-1egfkms","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"18:03:28","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-08-21 18:03，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-08-21-1754-33xe2m","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-08-21","time":"17:54:54","subject":"公告本公司舉辦2026年第一次線上法說會事宜","clause":"第12款","fact_date":"2026-08-27","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-08-21 17:54，「公告本公司舉辦2026年第一次線上法說會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6446-2026-08-21-1753-vqkii","company_id":"6446","company":"藥華藥","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"17:53:33","subject":"公告本公司註銷限制員工權利新股減資變更登記完成","clause":"第36款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：藥華藥（6446），2026-08-21 17:53，「公告本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-08-21-1722-eg0stb","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"17:22:43","subject":"公告本公司授權夥伴向澳洲藥品管理局申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記","clause":"第10款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-08-21 17:22，「公告本公司授權夥伴向澳洲藥品管理局申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-08-21-1701-1bjtlfy","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"17:01:09","subject":"公告本公司減資換發股票作業計畫業經核准事宜","clause":"第36款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-08-21 17:01，「公告本公司減資換發股票作業計畫業經核准事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-08-21-1646-vf5tgh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"16:46:31","subject":"(修正)本公司訂定現金減資基準日及調整減資比例","clause":"第11款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-08-21 16:46，「(修正)本公司訂定現金減資基準日及調整減資比例」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-08-21-1645-1oj2zvc","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-08-21","time":"16:45:36","subject":"代重要子公司育禾管理顧問股份有限公司公告會計主管異動","clause":"第11款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-08-21 16:45，「代重要子公司育禾管理顧問股份有限公司公告會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-08-21-1632-14hjczs","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-08-21","time":"16:32:13","subject":"本公司公告參與「臺北榮民總醫院醫療儀器設備（集中）採購案－微生物自動化檢驗軌道系統租賃案」接獲得標通知","clause":"第44款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-08-21 16:32，「本公司公告參與「臺北榮民總醫院醫療儀器設備（集中）採購案－微生物自動化檢驗軌道系統租賃案」接獲得標通知」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-08-21-1628-y4wqwx","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"16:28:50","subject":"公告本公司一針劑型及三針劑型透明質酸”FLEXVISC Plus”、”FLEXVISC”關節腔注射劑產品取得銷售許可證書","clause":"第51款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-08-21 16:28，「公告本公司一針劑型及三針劑型透明質酸”FLEXVISC Plus”、”FLEXVISC”關節腔注射劑產品取得銷售許可證書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-08-21-1606-rs6v8q","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"16:06:29","subject":"公告本公司受邀參加元大證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-08-25","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-08-21 16:06，「公告本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-08-21-1539-11iba0h","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-08-21","time":"15:39:15","subject":"公告本公司庫藏股減資變更登記完成","clause":"第36款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-08-21 15:39，「公告本公司庫藏股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-08-21-1522-r0d0ej","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-08-21","time":"15:22:14","subject":"本公司受邀參加康和證券所舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-08-27","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-08-21 15:22，「本公司受邀參加康和證券所舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-08-21-1459-1c5feq7","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-08-21","time":"14:59:38","subject":"(更正8/12公告之背書保證限額)公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第二款及第四款之公告標準","clause":"第22款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-08-21 14:59，「(更正8/12公告之背書保證限額)公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6431-2026-08-21-1431-9p3hlq","company_id":"6431","company":"光麗-KY","market":"上市","industry":"生技醫療","date":"2026-08-21","time":"14:31:46","subject":"公告本公司115年第2季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：光麗-KY（6431），2026-08-21 14:31，「公告本公司115年第2季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-08-21-1429-p67uuk","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-08-21","time":"14:29:09","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-08-21 14:29，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-08-21-0653-rbcvgp","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-08-21","time":"06:53:26","subject":"新藥OBP-301正式上市銷售","clause":"第53款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-08-21 06:53，「新藥OBP-301正式上市銷售」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}